Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Recruiting Phase 1 Interventional Study
Major Depressive Disorder Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 65
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
10 (estimated)
Sponsor
Yale University · Other
Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Healthy controls inclusion criteria: * Medically healthy * Psychiatrically healthy Healthy controls exclusion criteria: * Unstable medical conditions * Psychiatric illness Depression inclusion criteria: * Medically healthy * Diagnosis of major depressive disorder Depression exclusion criteria:…
Contacts

Hamideh Safi-Aghdam, MD

203-932-5711

hamideh.safi-aghdam@yale.edu

CONTACT